VulnerabilityModified

CVE-2018-14786

CRITICAL 9.4EPSS 3.06%

Does this matter?

High impact if exploited, but EPSS currently rates exploitation as unlikely (3.06%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.

Description

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

CVSS 3.0: 9.4 CRITICALCVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
EPSS: 3.06% probability · 87th percentile
CISA KEV: Not listed
Weakness: CWE-287
Affected: bd/alaris gs firmware · bd/alaris gh firmware · bd/alaris cc firmware · bd/alaris tiva firmware
Source: ics-cert@hq.dhs.gov

References

http://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-statesVendor Advisory
http://www.securityfocus.com/bid/105147Third Party Advisory, VDB Entry
https://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01Third Party Advisory, US Government Resource
http://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-statesVendor Advisory
http://www.securityfocus.com/bid/105147Third Party Advisory, VDB Entry
https://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01Third Party Advisory, US Government Resource

Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.